ZLAB
Zai Lab LimitedstockNASDAQADR
zai lab is a biopharmaceutical company dedicated to discovering, developing and commercializing innovative medicines. our vision is to address the largest unmet medical needs and transform patients' lives around the world. we take a unique approach to combine both in-licensed products and internal r&d; to achieve a rich pipeline. we believe our drug candidates can be truly disease modifying and bring significant benefits to patients. the company was founded in 2013 by a group of industry veterans. the founders are known as pioneers in china's fast advancing biotech industry with a proven track record for successful chinese cfda and us fda filings and approvals. our senior management team introduced fast regulatory approval pathways in china and developed a variety of partnership models with multinational pharmaceutical companies. we endeavor to conduct world class clinical development in china and beyond. zai lab has strong backing from a leading group of healthcare investors. our inve
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 26.04 | 2026-11-12 | -15.05% | -1.144 |
| 1M | 24.06 | 2026-10-19 | -8.06% | 1.180 |
| 3M | 26.72 | 2026-08-19 | -17.22% | 1.390 |
| 6M | 18.37 | 2026-05-19 | +20.41% | 1.164 |
| 1Y | 20.50 | 2025-11-19 | +7.90% | 1.028 |
| 2Y | 26.15 | 2024-11-19 | -15.41% | — |
| 5Y | 84.15 | 2021-11-19 | -73.71% | 1.173 |
Zai Lab Limited (NASDAQ:ZLAB) stock price today is $22.12, and today's volume is 1,043,536. ZLAB is down 5.992% today. The 30 day average volume is 1.15M. ZLAB market cap is $2.76B with 124.84M shares outstanding.